Richard R. Furman
9 Podcast Episodes
WM Case Discussions - Richard R. Furman, MD and Steven P. Treon, MD, PhD, FACP, FRCP
WM Case Discussions - Richard R. Furman, MD and Steven P. Treon, MD, PhD, FACP, FRCP
Understanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Thera... Read more
31 Dec 2019
•
30mins
Treatment for BTKi Progressors - Richard R. Furman, MD
Treatment for BTKi Progressors - Richard R. Furman, MD
First- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy
31 Dec 2019
•
20mins
Similar People
Sonia Friedman
Robert Sidbury
Jonathan Kay
Richard Kim
Stanley Cohen
Matt S
Atopic Dermatitis
Axel Grothey
Tanios Bekaii-Saab
Ghassan Abou-Alfa
Heinz-Josef Lenz
Rakesh Jain
Josep Tabernero
Jean-Yves Douillard
John Cooper
WM Case Discussions - Richard R. Furman, MD and Steven P. Treon, MD, PhD, FACP, FRCP
WM Case Discussions - Richard R. Furman, MD and Steven P. Treon, MD, PhD, FACP, FRCP
Understanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Thera... Read more
31 Dec 2019
•
30mins
Richard R. Furman, MD: Case on R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Richard R. Furman, MD: Case on R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Webcast: CLL in the Era of Targeted Therapy: Next Steps in Personalizing Management to Achieve Cure
30 Apr 2019
•
20mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Richard R. Furman, MD: Case on R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Richard R. Furman, MD: Case on R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Webcast: CLL in the Era of Targeted Therapy: Next Steps in Personalizing Management to Achieve Cure
30 Apr 2019
•
20mins
Richard R. Furman, MD: Novel Treatment Options in CLL
Richard R. Furman, MD: Novel Treatment Options in CLL
Webcast: CLL in the Era of Targeted Therapy: Next Steps in Personalizing Management to Achieve Cure
30 Apr 2019
•
27mins
Richard R. Furman, MD: Update on venetoclax: How low can you go (MRD)?
Richard R. Furman, MD: Update on venetoclax: How low can you go (MRD)?
Webcast: Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents... Read more
31 Oct 2018
•
21mins
Morton Coleman, MD and Richard R. Furman, MD: Highlights in Chronic Lymphocytic Leukemia
Morton Coleman, MD and Richard R. Furman, MD: Highlights in Chronic Lymphocytic Leukemia
Key Insights: Lymphoma and Myeloma 2018: An International Congress on Hematologic Malignancies
31 Oct 2018
•
22mins
Richard R. Furman, MD: Update on venetoclax: How low can you go (MRD)?
Richard R. Furman, MD: Update on venetoclax: How low can you go (MRD)?
Webcast: Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents... Read more
31 Oct 2018
•
21mins
